Division of Nephrology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, USA.
Curr Hypertens Rep. 2013 Jun;15(3):224-31. doi: 10.1007/s11906-013-0334-7.
The obesity epidemic has become a common concern among pediatricians, with an estimated 32 % of US children and adolescents classified as overweight and 18 % as obese. Along with the increase in obesity, a growing body of evidence demonstrates that chronic diseases, such as Type 2 diabetes, primary hypertension, and hyperlipidemia, once thought to be confined solely to adulthood, are commonly seen among the obese in childhood. Following a brief summary of the diagnosis and evaluation of hypertension in obese children and adolescents, this review will highlight recent research on the treatment of obesity-related hypertension. Pharmacologic and non-pharmacologic treatment will be discussed. Additionally, current and emerging therapies for the primary treatment of obesity in children and adolescents, which have been gaining in popularity, will be reviewed.
肥胖症已成为儿科医生普遍关注的问题，据估计，美国有 32%的儿童和青少年超重，18%肥胖。随着肥胖症的增加，越来越多的证据表明，曾经被认为仅局限于成年期的慢性疾病，如 2 型糖尿病、原发性高血压和高脂血症，在儿童肥胖中也很常见。在简要总结肥胖儿童和青少年高血压的诊断和评估后，本综述将重点介绍肥胖相关高血压治疗的最新研究。将讨论药物和非药物治疗。此外，还将回顾目前和新兴的儿童和青少年肥胖的主要治疗方法，这些方法越来越受欢迎。
